Below are some details I just received in my email. I thought you might like to review it. I could not find out where to sign up for telemedicine. I suppose there are people already signed up to provide that service and they will be getting busier. I bolded a few things that caught my attention. I see someone has brought up my thought that we need to investigate non-addictive pain medicines, vaccines and pain management techniques. I believe more emphasis has to be put into this area. The same amount of money, time and resources should be spent on managing pain as we did on HIV/AIDS research. We can win this battle if we have a mind to do it.
A PUBLIC HEALTH EMERGENCY: President Donald J. Trump is mobilizing his entire Administration to address drug addiction and opioid abuse by directing the declaration of a Nationwide Public Health Emergency to address the opioids crisis.
- The action allows for expanded access to telemedicine services, including services involving remote prescribing of medicine commonly used for substance abuse or mental health treatment.
- The action helps overcome bureaucratic delays and inefficiencies in the hiring process, by allowing the Department of Health and Human Services to more quickly make temporary appointments of specialists with the tools and talent needed to respond effectively to our Nation’s ongoing public health emergency.
- The actions allows the Department of Labor to issue dislocated worker grants to help workers who have been displaced from the workforce because of the opioid crisis, subject to available funding.
- The action allows for shifting of resources within HIV/AIDS programs to help people eligible for those programs receive substance abuse treatment, which is important given the connection between HIV transmission and substance abuse.
The Trump White House has moved quickly to address the drug addiction and opioid crisis, with the President’s Commission on Combating Drug Addiction and the Opioid Crisis leading the way.
- In March 2017, President Trump established the President’s Commission on Combating Drug Addiction and the Opioid Crisis, with the following stated mission: “to study the scope and effectiveness of the Federal response to drug addiction and the opioid crisis and to make recommendations to the President for improving that response.”
- President Trump eagerly awaits the Commission’s final report so that he can review their findings and recommendations.
- Since President Trump took office, more than $1 billion in funding has been allocated or spent directly addressing the drug addiction and opioid crisis.
- Since April, more than $800 million has been distributed for prevention, treatment, first responders, prescription drug monitoring programs, recovery and other care in communities, inpatient settings, and correctional systems.
- Since the President took office, $254 million in funding for high-risk communities, law enforcement, and first responder coordination and work has been awarded.
- The CDC has launched the Prescription Awareness Campaign, a multimedia awareness campaign featuring the real-life stories of people who have lost loved ones to prescription opioid overdose and people in recovery.
- The Food and Drug Administration is imposing new requirements on the manufacturers of prescription opioids to help reverse the overprescribing that has fueled the crisis.
- The Department of Justice’s Opioid Fraud and Abuse Detection Unit is targeting individuals that are contributing to the prescription opioid epidemic, has netted the largest-ever health care fraud takedown, secured the first-ever indictments against Chinese fentanyl manufacturers, and seized AlphaBay, the largest criminal marketplace on the Internet and a major source of fentanyl and heroin.
- The State Department has secured a binding UN agreement making it harder for criminals to access fentanyl precursors ANPP and NPP.
- The National Institutes of Health has initiated discussions with the pharmaceutical industry to establish a partnership to investigate non-addictive pain relievers and new addiction and overdose treatments, as well as a potential vaccine for addiction.
- The Department of Defense, Department of Veterans Affairs, National Institutes of Health, and Department of Health and Human Services are collaborating on a six-year, $81 million joint research partnership focusing on nondrug approaches to managing pain in order to address the needs of service members and veterans.